Certara stock.
Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ...
According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference between the total assets and total liabilities of a company.The high quality of our work is the result of dedication, collaboration, and deep expertise. By choosing to partner with Certara, you tap into the expertise and insights of more than 1,100 leading drug development, regulatory science, and market access solutions’ experts who are committed to finding the right answers and increasing the probability of your success.Certara, Inc. (CERT Quick Quote CERT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?5.27 M Change from Last -18.62% Percent of Float 4.84% Research & Ratings Certara Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range Consensus More View the latest Certara Inc....Dec 1, 2023 · The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share.
Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.
Certara recently reported its Q4 2022 financial results, beating revenue and EPS consensus estimates. Read more to know why I rate CERT stock as a hold.
Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock?Or log in with. Google Twitter1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Here are three high-yield tech stocks worth considering right now. With its stock down around 10% over the past year and a dividend yielding 3.4% annually as of this writing, semiconductor giant ...Certara Inc. stock grades by Barron's. ... Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.
Dec 1, 2023 · Certara Inc stock has a Value Score of 15, Momentum Score of 49 and Estimate Revisions Score of 29. Comparing Samsara Inc and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.
Dec 1, 2023 · Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.
Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Nov 24, 2023 · Bank of Montreal Can purchased a new stake in shares of Certara, Inc. (NASDAQ:CERT – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,490 shares of the company’s stock, valued at approximately $194,000. A number of other hedge funds and other institutional […] The estimated Net Worth of William F Feehery is at least $78.7 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.How much is Certara stock worth today? ( NASDAQ: CERT) Certara currently has 159,844,780 outstanding shares. With Certara stock trading at $14.64 per share, the total value of Certara stock (market capitalization) is $2.34B. Certara stock was originally listed at a price of $33.59 in Dec 14, 2020.Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.
In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ...Q3 2023 Certara Inc Earnings Call. Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.22 Nov 2023 ... Certara accelerates medicines to patients using proprietary biosimulation ... Share. Save. Report. Comments. thumbnail-image. Add a comment...Open $0.9454. Day Range 0.9230 - 1.0100. 52 Week Range 0.7078 - 1.6300. Market Cap $454.63M. Shares Outstanding 399.78M. Public Float 370.52M. Beta 1.69. Rev. per Employee $3.692M. P/E Ratio N/A.PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public …
PRINCETON, N.J.—September 3, 2021. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and ...
Find the latest TETRA Technologies, Inc. (TTI) stock quote, history, news and other vital information to help you with your stock trading and investing.Michael Schemick CERT stock SEC Form 4 insiders trading. Michael has made over 8 trades of the Certara stock since 2019, according to the Form 4 filled with the SEC. Most recently Michael exercised 13,302 units of CERT stock worth $199,131 on 31 March 2023.. The largest trade Michael's ever made was selling 66,667 units of Certara …13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.A Barchart Premier membership lets you screen on these options using advanced filters, including strategies for Covered Calls, Naked Puts and Option Spreads ...Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...Nov 30, 2023 · Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. New metrics and analytics capabilities enable informed decision making for biopharmaceutical clientsPRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf ... - Certara - Investor Tools. Print Page. Email Alerts ...Real time Certara (CERT) stock price quote, stock graph, news & analysis.
Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock?
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its …
Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ...PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public …Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.Certara, Inc. (NASDAQ: CERT) stock sentiment score is-15 as of the last check on Friday, November 03.That’s a change of -50.00 points from its previous day’s sentiment score of 35.00.-50.00 points from its previous day’s sentiment score of 35.00.A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the …Which Certara insiders have been buying company stock? The following insiders have purchased CERT shares in the last 24 months: Eran Broshy ($3,107.30), Michael Andrew Schemick ($416,000.00), and Stephen M Mclean ($326,400.00).
The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ...Certara, Inc. (NASDAQ:CERT), is not the largest company out there, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US ...Instagram:https://instagram. best short etf1964 kennedy silver half dollar coin valuefinancial advisors pittsburghcomputer stock Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday … brighton best internationaltop 10 reit stocks According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...PRINCETON, N.J.—September 3, 2021. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and ... tesla price reduce Certara Inc stock performance at a glance. Check Certara Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact:At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.